Usefulness of microalbuminuria in cardiovascular risk stratification of essential hypertensive patients

Nephron - Clinical Practice

Volumn 96, Issue 4, 2004, Pages

  Cerasola, Giovanni ^a   Mulè, Giuseppe ^a   Nardi, Emilio ^a   Cottone, Santina ^a   Andronico, Giuseppe ^a   Mongiovì, Rosalia ^a   Mezzatesta, Gianfranco ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cardiovascular risk; Hypertension; Left ventricular hypertrophy; Microalbuminuria

Indexed keywords

ALBUMIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; MICROALBUMINURIA; PATIENT CODING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; RETROSPECTIVE STUDY; RISK; STATISTICAL SIGNIFICANCE;

ALBUMINURIA; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OPHTHALMOSCOPY; PROGNOSIS; RETINA; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 2342446791     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077374     Document Type: Article

References (38)

1. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;i:1430 -1432.
2. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes mellitus. N Engl J Med 1984;310:356-360.
3. Dinneen SF, Gerstein HC: The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: A systematic overview of the literature. Arch Intern Med 1997;157:1413-1418.
4. Cerasola G, Cottone S, D'Ignoto G, Grasso L, Mangano MT, Carapelle E, et al: Microalbuminuria as a predictor of cardiovascular damage in essential hypertension. J Hypertens 1989;7(suppl):332-333.
5. Agrawal B, Berger A, Wolf K, Luft FC: Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996;14:223-228.
6. Cerasola G, Cottone S, Mule G, Nardi E, Mangano MT, Andronico G, et al: Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens 1996;14:915-920.
7. Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, et al: Prevalence and clinical correlates of microalbuminuria in essential hypertension: The MAGIC Study. Hypertension 1997;30:1135-1143.
8. Andronico G, Ferrara L, Mangano M, Mule G, Cerasola G: Insulin, sodium-lithium counter-transport and microalbuminuria in hypertensive patients. Hypertension 1998;31:110-113.
9. Wachtell K, Olsen MH, Dahlof B, Devereux RB, Kjeldsen SE, Nieminen MS, et al: Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. J Hypertens 2002;20:405-412.
10. Wachtell K, Palmieri V, Olsen MH, Bella JN, Aalto T, Dahlof B, et al: Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 2002;143:319-326.
11. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988;ii:530-503.
12. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Microalbuminuria as predictor of increased mortality in elderly people. BMJ 1990;300:297-300.
13. Ljungman S, Wikstrand J, Hartford M, Berglund G: Urinary albumin excretion - a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 1996;9:770-778.
14. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM, et al: Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects. Five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999;19:617-624.
15. Campese VM, Bianchi S, Bigazzi R: Microalbuminuria in essential hypertension: Significance, pathophysiology, and therapeutic implications. Am J Kidney Dis 1999;34:973-995.
16. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K: Arterial hypertension, microalbuminuria and risk of ischemic heart disease. Hypertension 2000;35:898-903.
17. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al: HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-426.
18. Pedrinelli R, Dell'Omo G, Di Bello V, Pontremoli R, Mariani M: Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens 2002;16:79-89.
19. Hillege HL, Fidler V, Diercks GFH, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al for the Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106:1777-1782.
20. Lorell BH, Carabello BA: Left ventricular hypertrophy. Pathogenesis, detection and prognosis. Circulation 2000;102:470-479.
21. Vakili BA, Okin PM, Devereux RB: Prognostic implications of left ventricular hypertrophy. Am Heart J 2001;141:334-341.
22. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999;17:151-183.
23. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-1053.
24. Expert Committee on the Diagnosis and Classification of Diabetes mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Diabetes Care 1997;20:1183-1197.
25. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al: Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol 1998;31:383-390.
26. Sahn DJ, DeMaria A, Kisslo J, Weiman A: The Committee on M-Mode Standardization of The American Society of Echocardiography. Circulation 1978;58:1072-1073.
27. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
28. De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, et al: Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and the impact of overweight. J Am Coll Cardiol 1992;20:1251-1060.
29. De Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH: Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and of their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995;25:1056-1062.
30. Liao Y, Cooper RS, Durazo-Arvizu R, Mensah GA, Ghali GK: Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997;29:641-647.
31. Keith NM, Wagener HP, Barker NW: Some different types of essential hypertension: Their course and prognosis. Am J Med Sci 1939;197:332-343.
32. Dimmitt SB, West JN, Eames SM, Gibson JM, Gosling P, Littler WA, et al: Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet 1989;i:1103-1106.
33. Fuchs FD, Maestri MK, Bredemeier M, Cardozo SE, Moreira FC, Wainstein MV, et al: Study of the usefulness of optic fundi examination of patients with hypertension in a clinical setting. J Hum Hypertens 1995;9:547-551.
34. Cuspidi M, Lonati L, Macca G, Sampieri L, Fusi V, Severgnini B, et al: Cardiovascular risk stratification in hypertensive patients: Impact of echocardiography and carotid ultrasonography. J Hypertens 2001;19:375-380.
35. Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zanchetti A on behalf of the APROS Investigators: Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: The Assessment of Prognostic Risk Observational Survey. J Hypertens 2002;20:1307-1314.
36. Leoncini G, Sacchi G, Viazzi F, Ravera M, Parodi D, Ratto E, et al: Microalbuminuria identifies overall cardiovascular risk in essential hypertension: An artificial neural networkbased approach. J Hypertens 2002;20:1315-1321.
37. Schillaci G, De Simone G, Reboldi G, Porcellati C, Devereux RB, Verdecchia P: Change in cardiovascular risk profile by echocardiography in low- or medium-risk hypertension. J Hypertens 2002;20:1519-1525.
38. Wong TY, Klein R, Klein BEK, Tielsch JM, Hubbard L, Nieto FJ: Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease and mortality. Surv Ophthalmol 2001;46:59-80.